TREA

90702290 - MYMODFA

Follow

Information

  • Trademark
  • 90702290
  • Serial Number
    90702290
  • Filing Date
    May 11, 2021
    3 years ago
  • Transaction Date
    October 01, 2024
    3 months ago
  • Status Date
    September 30, 2024
    3 months ago
  • Published for Opposition Date
    August 23, 2022
    2 years ago
  • Location Date
    October 18, 2022
    2 years ago
  • Status Code
    733
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    COHEN, ROBERT
  • Attorney Docket Number
    00159808-US
    Attorney Name
    Marilyn F. Kelly
    Law Office Assigned Location Code
    L30
  • Owners
Information
Mark Drawing Code
4
Mark Identification
MYMODFA
Case File Statements
  • GS0051: Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; monoclonal antibodies for therapeutic use for treating viral infections, inflammatory diseases, cardiovascular diseases, auto-immune diseases, blood diseases, and cancers
Case File Event Statements
  • 5/14/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 8/10/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/21/2022 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/21/2022 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/21/2022 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/18/2022 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/18/2022 - 2 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/18/2022 - 2 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/20/2022 - 2 years ago
    13 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 7/18/2022 - 2 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/20/2022 - 2 years ago
    10 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/20/2022 - 2 years ago
    11 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 7/20/2022 - 2 years ago
    12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 7/20/2022 - 2 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/3/2022 - 2 years ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/23/2022 - 2 years ago
    16 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/23/2022 - 2 years ago
    17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/29/2023 - a year ago
    20 - SOU EXTENSION 1 FILED Type: EXT1
  • 3/29/2023 - a year ago
    21 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 3/31/2023 - a year ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/3/2023 - a year ago
    23 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/3/2023 - a year ago
    24 - SOU EXTENSION 2 FILED Type: EXT2
  • 10/18/2022 - 2 years ago
    18 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 3/29/2023 - a year ago
    19 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/3/2023 - a year ago
    25 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 10/5/2023 - a year ago
    26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 9/30/2024 - 3 months ago
    31 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 9/30/2024 - 3 months ago
    34 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 9/30/2024 - 3 months ago
    33 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 9/30/2024 - 3 months ago
    32 - SOU EXTENSION 4 FILED Type: EXT4
  • 3/15/2024 - 10 months ago
    30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 3/14/2024 - 10 months ago
    29 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 3/14/2024 - 10 months ago
    27 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 3/14/2024 - 10 months ago
    28 - SOU EXTENSION 3 FILED Type: EXT3